Semaglutide -Novel Anti Obesity Medication for Weight Loss Landmark Study by NEJM [lIoszoKCSMu]

Semaglutide -Novel Anti Obesity Medication for Weight Loss Landmark Study by NEJM [lIoszoKCSMu]

| 1h 28m 28s | Video has closed captioning.

Visit for more information. Dr Srinivas Kota discusses a landmark study of GLP-1 Agonist Semaglutide for Medical Weight Loss and Medical Weight Management #noom diet pills #best diet pills sold in stores #keto gummies coles

Aired: January 05, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Related to This Episode

  • Q&A with Heidi Thomas

    Q&A with Heidi Thomas

    Writer & Executive Producer of Semaglutide -Novel Anti Obesity Medication for Weight Loss Landmark Study by NEJM [lIoszoKCSMu] on the secret of the show.

  • Relive the Drama with Gif Recaps

    Relive the Drama with Gif Recaps

    Miss an episode? Catch up on all things Poplar with our gif recaps.

  • Visit the Official Site

    Visit the Official Site

    Dive deeper into Semaglutide -Novel Anti Obesity Medication for Weight Loss Landmark Study by NEJM [lIoszoKCSMu] with cast Q&As, expert blogs, BTS photos, and more!

  • Explore the Modern Midwives Blog

    Explore the Modern Midwives Blog

    Experienced midwives discuss how Semaglutide -Novel Anti Obesity Medication for Weight Loss Landmark Study by NEJM [lIoszoKCSMu] intersects with modern day Midwifery.

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now